TP53TG3B

Q-omics provides the consensus-scored TP53TG3B profile across patient tissues and cancer cell-line models. TP53TG3B expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in SCLC. Additionally, TP53TG3B RNA expression shows 131 significant gene co-expression associations, with the highest sampling consensus in SCLC. Together, these results highlight SCLC as cancer lineages where TP53TG3B shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes TP53TG3B survival associations across molecular data types. TP53TG3B RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

TP53TG3B data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	SCLC (36)	view →

This table ranks reproducible TP53TG3B RNA expression–survival associations across cancer types. High TP53TG3B expression shows unfavorable associations in SCLC. The SCLC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify SCLC as the clearest survival context for TP53TG3B RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SCLC	OS	Tertile	III,IV	0.313	0.728	<.001	36	view →

Pink = unfavorable, green = favorable. all 1 lineages →

TP53TG3B-SCLC (OS)

Explore this curve interactively →